SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-109358
Filing Date
2015-03-27
Accepted
2015-03-27 16:00:53
Documents
4
Period of Report
2015-05-11
Effectiveness Date
2015-03-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d897143ddef14a.htm DEF 14A 301105
2 GRAPHIC g897143001.jpg GRAPHIC 6340
3 GRAPHIC g8971431.jpg GRAPHIC 5796
4 GRAPHIC g8971432.jpg GRAPHIC 5664
  Complete submission text file 0001193125-15-109358.txt   327229
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36327 | Film No.: 15730921
SIC: 2834 Pharmaceutical Preparations